A1 TNF Receptor Variant
- Date:
- 1990-1999
- Reference:
- SA/KET/A/4/1/1
- Part of:
- The Kennedy Trust for Rheumatology Research
- Archives and manuscripts
About this work
Description
Item relates to patent A1 "TNF Receptor Variant," invented by Marc Feldmann, Patrick Gray, Martin Turner and Fionula Brennan under applicant The Charing Cross Sunley Research Centre. The patent was filed in collaboration with pharmaceutical company XENOVA. The patent is also referred to as "Polypeptide and Its Use" and 'Soluble Human TNF Receptor."
The item contains papers relating to the filing and prosecution progress for British, US, Japanese, European and International applications.
See related material for A1 Espacenet listing (includes patent abstract and digital copies of application).
Publication/Creation
1990-1999
Physical description
1 file (in 3 parts)
Related material
patent link
Terms of use
This item is held in offsite storage and requires a longer time for delivery.
Where to find it
Location Status Access Closed stores